Material created by Roche. | All rights reserved - reproduction in whole or in part is prohibited without the prior written authorization of Roche Servicios S.A.
This material may contain information regarding investigational medicinal products or active substances, or indications not yet approved in your country, with the aim of providing medical and/or scientific information of interest to healthcare professionals. Roche does not recommend the use of any product in any indication, dosage, or route of administration that is not clearly listed in the product insert or marketing authorization approved by the local regulatory authority.
For healthcare professionals only.
A space for risk prevention in the use of medicines.
Report an adverse event or contact a medical expert on Roche products through Medinfo.
Pharmacovigilance is responsible for monitoring the safety of medicines from their development and throughout their life cycle. It performs activities for the detection, assessment, understanding and prevention of adverse events that may occur with the use of medicines.
Any drug has the potential to trigger adverse events, even those involving a long process of development, research and manufacturing under rigorous quality conditions.
Pharmacovigilance is a responsibility shared by healthcare professionals, the pharmaceutical industry, health authorities and patients. The activities carried out by Pharmacovigilance favor the rational and safe use of medicines for the benefit of our health.
Therefore, we invite you to contact us if you have any questions about the safety of our products.
The information provided will be kept confidential.
*Privacy policy for pharmacovigilance and medical information queries
Want to stay up-to-date on the latest news in medical innovation? Receive all the latest scientific research and technologies revolutionizing the healthcare sector directly to your inbox.
Register and select your areas of interest. Stay up to date!